Tag: Jotec

2000th E-liac Stent Graft System successfully implanted in the Netherlands

The 2000th E-liac stent graft (JOTEC) in the Netherlands was implanted successfully on the 20 June, JOTEC, a fully owned subsidiary of CryoLife has...

E-xtra Design Engineering prosthesis successfully implanted for the 3000th time

The 3,000th E-xtra Design Engineering vascular implant (Jotec/CryoLife) was recently inserted successfully. The endovascular implantation was performed at Cologne University’s academic teaching hospital, Porz...
CryoLife

CryoLife completes acquisition of Jotec

CryoLife, Inc, a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has completed its previously...
CryoLife

CryoLife announces definitive agreement to acquire Jotec

CryoLife has entered into a definitive agreement to acquire Jotec AG. A press release states that the combination of CryoLife and Jotec will create...

Disease-specific treatment solutions: Because no patient is like any other

In this supplement: -Individualised therapy through high-precision technology -Treatment of juxtarenal aneurysms with patient-adapted fenestrated stent graft solutions -Treatment of thoracoabdominal aneurysms with custom-made...

Piotr Szopinski: Developing the COLT endograft system for the treatment of...

Piotr Szopinski, Institute of Haematology and Transfusion Medicine, Warsaw, Poland, speaks to Vascular News at the 2016 VEITHSymposium about the development and use of...

Solutions for aortic disease: Consider the whole picture

Founded in 2000, JOTEC develops, manufactures and markets medical devices for aortic and peripheral vascular disease. This Educational Supplement looks at Jotec's broad product portfolio...

Enrolment in PLIANT study completed

Jotec has announced that it has completed enrolment in the PLIANT (Patients with iliac aneurysm undergoing endovascular stenting with a new generation of low...